Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Net revenues $ 2,140,726 $ 2,507,794
Cost of sales 990,274 1,805,739
Gross profit 1,150,452 702,055
Operating expenses:    
Research and development 1,650,050 20,611,127
Selling, general and administrative 8,301,431 17,545,865
Total operating expenses 9,951,481 38,156,992
Gain on sale of ENTADFI® assets 918,372  
Operating loss (7,882,657) (37,454,937)
Non-operating income (expenses):    
Interest expense (164,957) (873,230)
Change in fair value of derivative liabilities (2,000) (670,000)
Change in fair value of equity securities (379,898)  
Other income, net 81,092 220,932
Total non-operating expenses (465,763) (1,322,298)
Loss before income taxes (8,348,420) (38,777,235)
Income tax benefit (72,439) (68,278)
Net loss $ (8,275,981) $ (38,708,957)
Net loss per basic common shares outstanding $ (0.08) $ (0.48)
Basic weighted average common shares outstanding 100,601,946 80,558,670
Net loss per diluted common shares outstanding $ (0.08) $ (0.48)
Diluted weighted average common shares outstanding 100,601,946 80,558,670